And employers are paying for that mistake right now
I mean, if something funny hit me, I would write it down, but not working it, not writing
Homegrown firms are quickly moving via Phase 3 trials to challenge early market leaders, ensuring that Chinese companies will secure a major foothold in one of the world's fastest-growing drug classes
527 Currently, the drug is in Phase II clinical recruitment to compare the safety and efficacy of three different doses in patients with nAMD (NCT05637255)
Your at-home, full-body fitness solution in a bag
additional studies to evaluate the differences in adherence to combination therapy with GLP-1RA and SGLT2i compared with SGLT2i monotherapy and how these differences impact outcomes are needed